Furthermore, high frequencies of IFNγ-producing NPM1-mutated-specific T cells were persistently found in 13 of 15 (86.7%) patients, whose PB (52) or BM (28) samples were collected later than 12 months after AML diagnosis. This evidence concerns the gene IFNG and acute myeloid leukemia.